Maximum quantity allowed is 999
Please select the quantity
CAS RN: 5868-05-3 | Product Number: N0974
Niceritrol
Purity: >98.0%(HPLC)(qNMR)
Synonyms:
- Pentaerythritol Tetranicotinate
Product Documents:
Size | Unit Price | Same Day | 2-3 Business Days |
---|---|---|---|
25MG |
$130.00
|
14 | Contact Us |
100MG |
$389.00
|
5 | 1 |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Product Number | N0974 |
Purity / Analysis Method | >98.0%(HPLC)(qNMR) |
Molecular Formula / Molecular Weight | C__2__9H__2__4N__4O__8 = 556.53 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 5868-05-3 |
Reaxys Registry Number | 377170 |
PubChem Substance ID | 354333980 |
Merck Index (14) | 6497 |
MDL Number | MFCD00215982 |
Specifications
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(qNMR) | min. 98.0 % |
Melting point | 162.0 to 166.0 °C |
NMR | confirm to structure |
Properties (reference)
Melting Point | 165 °C |
GHS
Related Laws:
RTECS# | QT1980000 |
Transport Information:
H.S.code* | 2933.39-000 |
Application
血漿中脂質を低下し,末梢血管を拡張する化合物,ニセリトロール
Niceritrol is an ester of nicotinic acid [N0082] that suppresses free fatty acid (FFA) release from fat cells, and thereby lowers cholesterol and triglycerides in total plasma. Niceritrol also has peripheral tissue vasodilatory activity, and some studies suggest that niceritrol increases prostaglandin formation. In addition, niceritrol might be cause of hypophosphatemic action and thrombocytopenia and anemia, but the mechanisms of the actions are still unclear. (The product is for research purpose only.)
References
- Actions of vitamins A and E and some nicotinic acid derivatives on plasma lipids and on lipid infiltration of aorta in cholesterol-fed rabbits
- Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats
- Effects of niceritrol on fecal and urinary phosphate excretion in normal rats
- Thrombocytopenia and Anemia Induced by Niceritrol Used for Amelioration of Hyperphosphatemia in a Hemodialysis Patient
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.